Literature DB >> 26397768

Predictors of 30-day readmission after mastectomy: A multi-institutional analysis of 21,271 patients.

Ian Chow1, Philip J Hanwright1, Nora M Hansen2, Solmaz N Leilabadi1, John Y S Kim1.   

Abstract

BACKGROUND: Recent healthcare legislation has made unplanned hospital readmission an important metric of health care quality, and current efforts center on reducing this complication in order to avoid fiduciary penalties.
OBJECTIVE: There is currently a paucity of data delineating risk factors for readmission following mastectomy. To this end, we sought to develop a predictive model of unplanned readmissions following mastectomy.
METHODS: The 2011 and 2012 National Surgical Quality Improvement Program (NSQIP) datasets were retrospectively queried to identify patients who underwent mastectomy. Multivariate logistic regression modeling was used to identify risk factors for readmission.
RESULTS: Of 21,271 patients meeting inclusion criteria, 1,190 (5.59%) were readmitted. The most commonly cited reasons for readmission included surgical site complications (32.85%), infection not localized to the surgical site (2.72%), and venous thromboembolism (4.39%). Independent predictors of readmission included BMI, active smoking status, and skin-sparing mastectomy. Significantly, concurrent breast reconstruction and bilateral mastectomy were not independent predictors of readmission.
CONCLUSIONS: This is the first study of readmission rates after mastectomy. Awareness of specific risk factors for readmission, particularly those that are modifiable, may serve to identify and manage high risk patients, aid in the development of pre- and postoperative clinical care guidelines, and ultimately improve patient care.

Entities:  

Keywords:  30-day; mastectomy; outcomes; readmission; risk factors

Mesh:

Year:  2015        PMID: 26397768     DOI: 10.3233/BD-150412

Source DB:  PubMed          Journal:  Breast Dis        ISSN: 0888-6008


  8 in total

1.  Does neoadjuvant chemotherapy affect morbidity, mortality, reoperations, or readmissions in patients undergoing lumpectomy or mastectomy for breast cancer?

Authors:  Jeffrey Landercasper; Barbara Bennie; Mallory S Bray; Choua A Vang; Jared H Linebarger
Journal:  Gland Surg       Date:  2017-02

2.  Comparison of short-term surgical outcomes between men and women with breast cancer: a retrospective study using nationwide inpatient data in Japan.

Authors:  Takaaki Konishi; Michimasa Fujiogi; Nobuaki Michihata; Kojiro Morita; Hiroki Matsui; Kiyohide Fushimi; Masahiko Tanabe; Yasuyuki Seto; Hideo Yasunaga
Journal:  Breast Cancer Res Treat       Date:  2021-01-05       Impact factor: 4.872

3.  Late Surgical-Site Infection in Immediate Implant-Based Breast Reconstruction.

Authors:  Indranil Sinha; Andrea L Pusic; Edwin G Wilkins; Jennifer B Hamill; Xiaoxue Chen; Hyungjin M Kim; Gretchen Guldbrandsen; Yoon S Chun
Journal:  Plast Reconstr Surg       Date:  2017-01       Impact factor: 4.730

4.  The Quest for Outpatient Mastectomy in COVID-19 Era: Barriers and Facilitators.

Authors:  L J van Zeelst; R Derksen; C H W Wijers; J Hegeman; R Berry; J H W de Wilt; L J A Strobbe
Journal:  Breast J       Date:  2022-06-01       Impact factor: 2.269

5.  Unplanned Emergency Department Visits within 30 Days of Mastectomy and Breast Reconstruction.

Authors:  Jacob S Nasser; Helen E Huetteman; Ting-Ting Chung; Kevin C Chung
Journal:  Plast Reconstr Surg       Date:  2018-12       Impact factor: 4.730

6.  Indications for readmission following mastectomy for breast cancer: An assessment of patient and operative factors.

Authors:  Jennifer Yu; Margaret A Olsen; Julie A Margenthaler
Journal:  Breast J       Date:  2020-08-26       Impact factor: 2.431

7.  Factors associated with readmissions in women participating in screening programs and treated for breast cancer: a retrospective cohort study.

Authors:  Carme Miret; Laia Domingo; Javier Louro; Teresa Barata; Marisa Baré; Joana Ferrer; Maria Carmen Carmona-García; Xavier Castells; Maria Sala
Journal:  BMC Health Serv Res       Date:  2019-12-05       Impact factor: 2.655

8.  Surgical Outcomes for Mastectomy Patients Receiving Neoadjuvant Chemotherapy: A Propensity-Matched Analysis.

Authors:  Megan E Bowen; Mary C Mone; Saundra S Buys; Xiaoming Sheng; Edward W Nelson
Journal:  Ann Surg       Date:  2017-03       Impact factor: 12.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.